Crewe Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-150	Closed	-$2.82K	–	871
2023 Q1	$2.82K	Sell	150 -89	-37%	-$1.68K	﹤0.01%	696
2022 Q4	$3.81K	Sell	239 -158	-40%	-$2.52K	﹤0.01%	728
2022 Q3	$6K	Hold	397	–	–	﹤0.01%	785
2022 Q2	$6K	Buy	+397	New	+$6K	﹤0.01%	705